VitalMIST provides low-tech, inexpensive, and non-invasive nasal atomization solutions. Our products give clinics and patients assurance that their medication is being delivered sufficiently, every time.
Our company was founded by international developers and it is our mission to ensure everyone has access to devices which prevent and treat disease and illness. We are currently looking to establish partnerships with device manufacturers in developing countries to provide our solution at a fraction of the cost of our competitors.
Nasal atomization allows for rapid absorption of the prescription medication given to a patient suffering from opioid overdose.
The use of a nasal atomizer is safer for the patient and healthcare provider for when administering seizure medication.
Millions of Canadians are opting to receive seasonal flu vaccines and intranasal vaccines introduce the possibility of non-invasive, self-administration for patients.
Intranasal sedation is ideal for many young patients suffering from heightened operative anxiety from the use of intramuscular injections.
Intranasal pain medication is an attractive alternative when intravenous access is limited.
The VitalMIST nozzle design produces a constant stream of medication, at any angle. Each use evenly distributes the prescribed medication across the mucosal membranes for rapid absorption.
Our team has designed the VitalMIST nozzle to ensure our customers and patients receive quality drug administration at a competitive cost.
VitalMIST’s social responsibility program is inseparable from its mission of delivering devices, which prevent and treat disease and illness, to everyone. Our customers help establish partnerships with device manufacturers in developing countries to deliver our product to those in need.
Can't decide? Don't hesitate to contact us.
In a double-blind, phase II trial, participants given intranasal esketamine treatment showed a significant improvement in depressive symptoms, at 4 and 24 hours after treatment, when compared to the placebo.Read More →